Cardiometabolic Diseases Multimorbid with Anxiety and/or Depression
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient: 1. Age 60 years or older; 2. Diagnosed by a medical institution with at least one metabolic disorder—hypertension, diabetes, or dyslipidemia—and diagnosed with anxiety disorder, depressive disorder, or comorbid anxiety and depressive disorders according to the diagnostic criteria of either the "Clinical Practice Guidelines for Mental Disorders (2020 Edition)" or the "Clinical Descriptions and Diagnostic Criteria for Mental, Behavioral, and Neurodevelopmental Disorders" in the International Classification of Diseases, 11th Revision (ICD-11); 3. Blood pressure, fasting blood glucose, and lipid levels have been stable over the past four weeks, meaning no changes in treatment regimens (including medication type, dosage, and frequency), and no clinically significant fluctuations in monitoring indicators; no acute cardiovascular or cerebrovascular events or metabolic crises have occurred within the past four weeks; mental disorder is in a stable phase without acute episodes or marked symptom worsening; 4. Possesses basic skills in operating smartphones or tablets, capable of independently using mobile devices or with minimal assistance; 5. Fully informed about the study and voluntarily signs an informed consent form. Significant others: 1. Age 18 years or older; 2. Capable of clear verbal communication and able to provide informed consent; 3. A family member, neighbor, or friend designated by the elderly patient who engages in frequent emotional communication; 4. Possesses basic skills in operating smartphones or tablets, capable of independently using mobile devices.
Exclusion criteria
Exclusion criteria: For Patients: 1.Patients with impaired speech, hearing, or visual function, or with severe cognitive impairment that may affect their understanding of the study and cooperation. 2.Patients in the terminal stage of a disease with an estimated life expectancy of less than 6 months, who are unlikely to complete the full study participation. 3.Patients who have participated in other psychological intervention studies within the past 3 months, which may potentially affect the results of this study. 4.Patients who are unwilling to cooperate for other reasons. For significant others: 1.Individuals with serious mental disorders(schizophrenia) or cognitive impairments. 2.Individuals who are unwilling to cooperate for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive and negative emotion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety;Depression;Family Care Index;Quality of life;Blood pressure;Glycated hemoglobin;Total Cholesterol;Triglyceride;High-density lipoprotein;Low-density lipoprotein; | — |
Countries
China
Contacts
Soochow University